Clinical Trial Update: A Phase II Clinical Study of LBL-024 Combination Therapy in Patients With Advanced Solid Tumour[Substudy 03(ESCC)] [Phase 2]

View source ↗

Summary

Phase II study of LBL-024 in advanced solid tumours, including esophageal squamous cell carcinoma (substudy 03), is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• LBL-024

Snippet

Sponsor: Nanjing Leads Biolabs Co.,Ltd | Conditions: Advanced Solid Tumour | Phase 2 | Status: RECRUITING